Lanxes 50 Tablet contains Losartan 50mg, an angiotensin II receptor antagonist primarily indicated for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Lanxes 50 facilitates vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension, such as stroke, myocardial infarction, and renal impairment. Additionally, Lanxes 50 is utilized in the treatment of diabetic nephropathy in patients with type 2 diabetes and proteinuria, contributing to the preservation of renal function. The tablet is administered orally, typically once daily, with or without food, based on clinical judgment. Dosage adjustments may be necessary for patients with hepatic or renal impairment. Common adverse effects include dizziness, headache, and fatigue, while serious side effects are rare but may involve hyperkalemia or renal dysfunction. Lanxes 50 should be used cautiously in patients with bilateral renal artery stenosis or volume depletion. It is contraindicated during pregnancy due to the risk of fetal toxicity. Regular monitoring of blood pressure, renal function, and electrolytes is recommended to ensure therapeutic efficacy and safety. Lanxes 50 offers an effective option for blood pressure control and renal protection in appropriate patient populations.